IL18 and acute kidney injury: Our study lends further credence to the incorporation of NGAL and IL-18 into a multimodal diagnostic framework for early and accurate differentiation of AKI subtypes in DCLD, which may ultimately guide more tailored therapeutic interventions and improve patient outcomes.